Torrent Pharmaceuticals Limited
NSE:TORNTPHARM.NS
3,199.85 (INR) • At close November 8, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Torrent Pharmaceuticals Limited |
Symbool | TORNTPHARM.NS |
Munteenheid | INR |
Prijs | 3,199.85 |
Beurswaarde | 1,082,973,233,250 |
Dividendpercentage | 1.13% |
52-weken bereik | 2,024.65 - 3,590.7 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Samir Uttamlal Mehta B.Com., MBA |
Website | https://www.torrentpharma.com |
An error occurred while fetching data.
Over Torrent Pharmaceuticals Limited
Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, and marketing of generic pharmaceutical formulations in India, the United States, Germany, Brazil, and internationally. It offers products in various therapeutic areas, including cardiovascular, central nervous system, gastrointestinal, women healthcare, diabetology, pain management, gynecology, oncology, and anti-infective, as well as provides
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (INR)
Cijfers zijn in miljoenen (INR)